Literature DB >> 3693185

Pathological supply dependence of O2 uptake during bacteremia in dogs.

D P Nelson1, C Beyer, R W Samsel, L D Wood, P T Schumacker.   

Abstract

When systemic delivery of O2 [QO2 = cardiac output X arterial O2 content (CaO2)] is reduced, the systemic O2 extraction ratio [(CaO2-concentration of O2 in venous blood/CaO2] increases until a critical limit is reached below which O2 uptake (VO2) becomes limited by delivery. Many patients with adult respiratory distress syndrome exhibit supply dependence of VO2 even at high levels of QO2, which suggests that a peripheral O2 extraction defect may be present. Since many of these patients also suffer from serious bacterial infection, we tested the hypothesis that bacteremia might produce a similar defect in the ability of tissues to maintain VO2 independent of QO2, as QO2 reduced. The critical O2 delivery (QO2crit) and critical extraction ratio (ERcrit) were compared in a control group of dogs and a group receiving a continuous infusion of Pseudomonas aeruginosa (5 x 10(7) organisms/min). Dogs were anesthetized, paralyzed, and ventilated with room air. Systemic QO2 was reduced in stages by hemorrhage as hematocrit was maintained. At each stage, systemic VO2 and QO2 were measured, and the critical point was determined from a plot of VO2 vs. QO2. The mean QO2crit and ERcrit of the bacteremic group (11.4 +/- 2.2 ml.min-1.kg-1 and 0.51 +/- 0.09) were significantly different from control (7.4 +/- 1.2 and 0.71 +/- 0.10) (P less than 0.05). These results suggest that bacterial infection can reduce the ability of peripheral tissues to extract O2 from a limited supply, causing VO2 to become limited by O2 delivery at a stage when a smaller fraction of the delivered O2 has been extracted.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693185     DOI: 10.1152/jappl.1987.63.4.1487

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  26 in total

Review 1.  VO2/DO2 relationship: how to get rid of methodological pitfalls?

Authors:  D De Backer
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

2.  Theoretical comparison of wall-derived and erythrocyte-derived mechanisms for metabolic flow regulation in heterogeneous microvascular networks.

Authors:  Tuhin K Roy; Axel R Pries; Timothy W Secomb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

Review 3.  Oxygen delivery in the critically ill.

Authors:  J L Vincent
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

4.  Methods of monitoring shock.

Authors:  Ednan K Bajwa; Atul Malhotra; B Taylor Thompson
Journal:  Semin Respir Crit Care Med       Date:  2004-12       Impact factor: 3.119

5.  My paper 20 years later: effects of dobutamine on the VO₂/DO₂ relationship.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2014-09-30       Impact factor: 17.440

6.  Oxygen delivery and consumption in surfactant-depleted newborn piglets.

Authors:  X O Yu; A Moen; B A Feet; O D Saugstad
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 7.  Oxygen transport-the oxygen delivery controversy.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

Review 8.  Matching total body oxygen consumption and delivery: a crucial objective?

Authors:  Pierre Squara
Journal:  Intensive Care Med       Date:  2004-09-21       Impact factor: 17.440

9.  Significance of pathologic oxygen supply dependency in critically ill patients: comparison between measured and calculated methods.

Authors:  G Hanique; T Dugernier; P F Laterre; A Dougnac; J Roeseler; M S Reynaert
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  Evaluation of oxygen uptake and delivery in critically ill patients: a statistical reappraisal.

Authors:  G Hanique; T Dugernier; P F Laterre; J Roeseler; A Dougnac; M S Reynaert
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.